VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
UTI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
UTIUniversal Technical Institute, Inc.
$19.93$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksUTICash Flow

Universal Technical Institute, Inc. (UTI) Cash Flow Statement

26Y historyFree accessUpdated daily

Free cash flow swung to -$63.5M in 2026Q3 (FCF margin -29.0%) as CapEx spiked to 37.0% of revenue, while working capital absorbed $81.1M, despite operating cash flow of $17.4M covering net income 7.6 times.

Income StatementBalance SheetCash FlowRatios

UTI Cash Flow Statement

Annual statement

UTI Cash Flow Statement

Universal Technical Institute, Inc. (UTI) cash flow statement — 26-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00
Cash from Operations74.51M97.33M85.89M49.15M46.03M55.19M11.03M21.75M-13.48M-9.98M7.38M8.24M27.06M26.73M18.51M58.07M67.48M49.15M21.09M39.63M45.41M67.76M47.66M36.42M20.47M021.05M
Operating CF Margin %-11.65%11.72%8.09%10.99%16.47%3.67%6.56%-4.25%-3.08%2.13%2.27%7.15%7.03%4.48%12.85%15.48%13.41%6.14%11.22%13.09%21.8%18.68%18.53%14.18%-22.86%
Operating CF Growth %460.29%13.31%74.77%6.77%-16.59%400.23%-49.27%261.34%-35.08%-235.13%-10.41%-69.54%1.21%44.43%-68.13%-13.94%37.29%133.01%-46.78%-12.73%-32.98%42.18%30.88%77.89%--100%-
Net Income34.3M63.02M42M12.32M25.85M14.58M8.01M-7.87M-32.68M-8.13M-47.7M-9.15M2.04M3.81M9.03M27.24M28.83M11.73M8.22M15.56M27.39M35.82M28.82M20.38M9.92M-9.74M-36.22M
Depreciation & Amortization62.86M56.78M51.19M45.82M32.78M29.63M36.08M15.9M15.69M16.89M17.75M19.16M20.47M22.16M23.82M24.84M19.89M17.57M17.61M18.75M14.21M9.78M8.81M6.38M4.95M4.53M3.89M
Stock-Based Compensation12.18M9.15M8.56M3.85M4.34M1.73M2.08M1.39M1.81M2.94M4.9M4.26M5.72M6.22M6.49M6.28M5.89M4.7M5.33M6.44M1.21M808K808K0000
Deferred Taxes83K-1.34M4.44M4.64M-6.01M1.44M345K767K-2.81M254K27.93M-5.39M-4.05M-3.79M-8.49M2.51M-3.54M-2.17M-249K-957K-2.39M-1.7M3.3M484K2.04M00
Other Non-Cash Items31.38M23.86M7.99M5.22M7.84M351K2.26M863K2.44M-1.12M879K14.17M5.21M5.04M6.46M9.35M6.44M7.74M5.59M4.05M8.65M5.06M4.48M4M3.65M9.78M11.28M
Working Capital Changes-66.28M-54.15M-28.28M-22.7M-18.76M7.45M-37.73M10.69M2.07M-20.81M3.62M-14.81M-2.33M-6.71M-18.81M-12.15M9.97M9.58M-15.4M-4.22M-3.65M18M1.44M5.17M-94K-4.57M21.05M
Change in Receivables-44.48M-43.95M-17.93M-5.73M816K8.48M-13.75M-1.48M-2.69M-2.98M8.2M-11.44M-2.7M-1.26M-10.11M-9.89M-9.89M-1.94M-11.31M-1.63M-5.32M-2.56M-2.56M0000
Change in Inventory000-22.49M0-19.78M-21.75M5.08M2.5M522K-1.04M123K726K3.83M-4.05M-14.48M14.34M3.4M-5.57M-394K2.34M170K-9.18M-108K000
Change in Payables4.37M00-5.88M5.65M1.79M7.02M2.94M3.86M-4.76M1.85M2.71M-1.86M-700K3.04M6.04M6.04M6.99M109K-2.16M4.65M6.58M6.58M0000
Cash from Investing-89.34M-87.88M-24M-44.07M-134.6M-22.95M-45.76M-6.15M28.02M-52.17M17.35M-2.68M-9.2M-20.76M-16.58M-53.99M-42.12M-57.05M12.98M-6.39M-29.87M-61.48M-16.94M-11.65M-5.78M00
Capital Expenditures-97.38M-41.98M-24.3M-56.69M-79.46M-61.59M-9.26M-6.45M-20.93M-8.77M-8.07M-29.48M-12.02M-9.35M-11.34M-29.1M-37.2M-28.52M-17.7M-46.58M-46.14M-45.84M-16.98M-11.98M-11.77M00
CapEx % of Revenue11.02%5.02%3.32%9.33%18.97%18.38%3.08%1.95%6.6%2.7%2.32%8.13%3.18%2.46%2.74%6.44%8.53%7.78%5.15%13.18%13.29%14.75%6.65%6.1%8.15%--
Acquisitions000-16.38M-26.33M277K261K267K291K390K-2.02M464K568K54K-90.63M0000032M000000
Investments---------------------------
Other Investing-4.29M169K296K29M-181K427K1.63M34K917K2.26M286K610K91K-3.71M91.25M64K5K36K30.69M40.19M3K194K36K323K5.87M00
Cash from Financing77.37M-42.79M-51.34M81.85M12.59M24.82M43.09M-7.2M-6.58M-6.76M64.88M-15.11M-13.46M-15.98M-9.93M611K-32.59M-16.78M-28.79M918K-26.16M3.16M2.96M-29.39M-4.49M00
Debt Issued (Net)206.18M-38.7M-36.52M88.21M18.77M30.77M-99K-1.32M-1.11M-913K-736K-663K-613K0000000-6K-37K-31.83M-28.33M-63.35M00
Equity Issued (Net)-8.73M659K-23.01M-781K-651K-421K49.15M-629K-223K-595K68.89M-6.62M-1.42M-4.9M-1.3M1.27M4.08M-16.06M-29.05M861K-26.95M3.4M47.32M042.04M00
Dividends Paid00-1.1M-5.07M-5.16M-5.25M-5.26M-5.25M-5.25M-5.25M-2.88M-7.31M-9.88M-9.82M-7.42M-36.33M-36.33M0000-12.56M-12.56M-5M000
Share Repurchases-8.73M0-11.5M-781K-651K-421K0-629K-223K-595K0-6.62M-1.42M-5.42M-1.85M00-16.93M-29.54M0-30.03M0-12.95M0000
Other Financing-120.08M-4.75M9.28M-516K-378K-272K-698K000-393K-519K-1.55M-1.26M-1.21M-658K-336K-723K251K57K798K-199K28K3.94M16.82M00
Net Change in Cash62.53M-33.34M10.55M86.93M-75.98M57.06M8.36M8.4M7.97M-68.91M89.61M-9.55M4.39M-10.01M-8.01M4.7M-7.22M-24.68M5.28M34.16M-10.61M9.44M33.68M-4.63M10.2M021.05M
Free Cash Flow-22.87M55.35M61.6M-7.54M-33.43M-6.4M1.77M15.29M-34.41M-18.74M-686K-21.24M15.03M17.38M7.17M28.97M30.29M20.63M3.39M-6.95M-722K21.92M30.69M24.44M8.7M021.05M
FCF Margin %-2.59%6.62%8.41%-1.24%-7.98%-1.91%0.59%4.61%-10.86%-5.78%-0.2%-5.86%3.97%4.57%1.73%6.41%6.95%5.63%0.99%-1.97%-0.21%7.05%12.03%12.44%6.03%-22.86%
FCF Growth %-130.61%-10.14%917.26%77.45%-422.2%-461.64%-88.43%144.44%-83.58%-2632.22%96.77%-241.31%-13.51%142.51%-75.26%-4.33%46.82%508.65%148.78%-862.19%-103.29%-28.55%25.56%180.94%--100%-
FCF per Share-0.411.001.21-0.22-0.99-0.190.060.60-1.37-0.76-0.03-0.870.600.700.291.171.240.840.13-0.25-0.030.771.110.980.43-1.57
FCF Conversion (FCF/Net Income)-0.67x1.54x2.05x3.99x1.78x3.78x1.38x-2.76x0.41x1.23x-0.15x-0.90x13.28x7.02x2.05x2.13x2.34x4.19x2.57x2.55x1.66x1.89x1.65x1.79x2.11x--0.58x
Interest Paid-4.95M5.91M10.39M-9.07M-1.94M349K7K3.22M3.31M3.38M3.44M2.34M1.97M1K4K09K48K000000000
Taxes Paid-10.36M11.26M10.68M658K-859K6.71M113K37K610K2.7M1.64M7.01M3.77M7.47M15.71M12.62M23.12M7.82M000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

CapEx surge and working capital drag

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Earnings Quality Masked by Working Capital

In 2026Q3, UTI's operating cash flow of $17.4M was 7.6 times net income of $2.3M, but a $81.1M working capital outflow suggests earnings quality is heavily influenced by timing, per reported figures.

The OCF/NI ratio of 7.64 in 2026Q3 appears inflated by non-cash D&A of $48.0M, yet the massive working capital outflow of $81.1M indicates that cash generation is being consumed by operational needs. This divergence suggests that reported net income may not be a reliable indicator of cash-generating ability, as the company's cash conversion is volatile and dependent on working capital swings.

FCF Turns Sharply Negative

UTI's free cash flow swung from a positive $40.6M in 2025Q4 to a negative $63.5M in 2026Q3, with FCF margin deteriorating from 18.3% to -29.0%, according to the latest quarterly data.

The dramatic reversal in FCF is driven by a surge in capital expenditures to $80.9M in 2026Q3, up from $16.5M in the prior quarter, alongside a working capital outflow. This suggests that UTI is in a heavy investment phase, likely for campus expansions or new programs, which may pressure near-term cash flows despite revenue growth. Investors should monitor whether this investment translates into future revenue growth or if it strains liquidity.

Capital Intensity Spikes to 37%

CapEx as a percentage of revenue jumped to 37.0% in 2026Q3, up from 7.4% in 2025Q4, indicating a significant shift toward growth-oriented spending, as per financial statements.

The sharp increase in capital intensity suggests that UTI is investing heavily in fixed assets, likely to expand capacity or modernize facilities. While this may support long-term growth, the magnitude of the spending relative to revenue is unusually high and may strain cash flows if not matched by corresponding revenue increases. The company's ability to generate sufficient returns on this investment will be critical to sustaining its financial health.

Working Capital Swings Dominate Cash Flow

Working capital changes were a negative $81.1M in 2026Q3, reversing a positive $14.9M in 2025Q4, indicating significant cash absorption from operations, based on reported cash flow data.

The large working capital outflow in 2026Q3 suggests that UTI is experiencing a build-up in receivables or inventory, or a reduction in payables, which is consuming cash. This volatility in working capital is a key driver of the company's uneven cash flow pattern, and it may indicate inefficiencies in collections or inventory management. Analysts should monitor whether this is a seasonal effect or a sign of operational strain.

Minimal Capital Returns, Heavy Reinvestment

UTI paid no dividends and repurchased only $8.7M of stock in 2026Q3, while allocating $80.9M to capital expenditures, indicating a reinvestment-focused strategy, as per the cash flow statement.

The company's capital deployment is clearly skewed toward growth investments rather than returning cash to shareholders. With no dividends and modest buybacks, UTI appears to be prioritizing expansion, which aligns with its revenue growth trajectory. However, the lack of shareholder returns may be a concern for income-focused investors, and the effectiveness of this reinvestment strategy will be judged by future profitability.

Cumulative Cash Generation Lags Earnings

Over the last five quarters, UTI's cumulative operating cash flow of $188.4M exceeds cumulative net income of $109.7M, but the gap is narrowing due to recent working capital outflows, according to reported figures.

While operating cash flow has historically been stronger than net income, the recent quarters show a convergence, with 2026Q3's OCF/NI ratio of 7.64 masking the underlying cash consumption. The cumulative divergence suggests that earnings quality has been reasonable, but the recent working capital drag and heavy capex may indicate that future cash generation could be less robust. Investors should watch whether the company can maintain its cash conversion as it scales.

What Could Invalidate the Base Case

The reported cash flow may obscure the impact of stock-based compensation, which totaled $9.4M in 2026Q3, and the sustainability of the CapEx surge remains uncertain, per the cash flow statement.

While the cash flow statement shows strong operating cash flow relative to net income, the inclusion of SBC as a non-cash add-back may overstate cash generation. Additionally, the massive CapEx in 2026Q3 could be a one-time event or the start of a prolonged investment cycle, which would further pressure FCF. Investors should scrutinize whether the working capital outflows are temporary or indicative of structural inefficiencies, as this could materially alter the company's cash flow trajectory.

UTI — Frequently Asked Questions

Quick answers to the most common questions about buying UTI stock.

How much cash does Universal Technical Institute, Inc. (UTI) generate from operations?

Universal Technical Institute, Inc. (UTI) generated $97.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Universal Technical Institute, Inc.'s free cash flow?

Universal Technical Institute, Inc. (UTI) generated $55.4M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Universal Technical Institute, Inc.'s capital expenditure (CapEx)?

Universal Technical Institute, Inc. (UTI) spent $42.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.